Close

Draft Guidance on Assessment of Abuse Potential of Drugs

Mar 29 2010

Cellulosic Biofuel: BIO Asks Congress to Fund Reverse Auction

Mar 23 2010

...

BIO Priorities in FY2011 Labor, Health and Human Services, Education and Related Agencies Appropriations Act

Mar 23 2010

Letters urging funding for public health programs and initiatives which utilize biotechnology to help meet our nation’s unmet medical needs.

BIO comments to the Office of Management and Budget regarding "Introduction of Organisms and Products Altered or Produced Through Genetic Engineering"

Mar 23 2010

...

Draft Guidance on IRB Continuing Review After Clinical Investigation Approval

Mar 15 2010

BIO's comments regarding Inclusion of TRICARE Retail Pharmacy Program in Federal Procurement of Pharmaceuticals

Mar 11 2010

Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products

Mar 8 2010

Comments on the Centers for Medicare & Medicaid Services’ (CMS) Draft 2011 Call Letter

Mar 5 2010
The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) Draft 2011 Call Letter. BIO is the largest trade organization to serve and represent the biotechnology industry in the United States and around the world. BIO represents more than 1,200 biotechnology centers, academic institutions, state biotechnology centers, and related organizations in the United States and in more than 30 other nations. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products.

BIO Priorities in FY2011 State, Foreign Relations & Related Programs Appropriations Act

Mar 5 2010

BIO Priorities in FY2011 Energy & Water Appropriations Bill

Mar 5 2010